Prestige Consumer CFO reports tax share withholding

Prestige Consumer Healthcare Inc. executive Christine Sacco, the company’s CFO and COO, reported a tax-withholding disposition of 1,091 shares of common stock at a price of $55.09 per share.

Rhea-AI Filing Summary

Prestige Consumer Healthcare Inc. executive Christine Sacco, the company’s CFO and COO, reported a tax-withholding disposition of 1,091 shares of common stock at a price of $55.09 per share. This adjustment reflects a correction to an earlier inadvertent error and leaves her holding 57,374 shares directly.

Insider Trade Summary

Exercise Price or Tax Liability: 1,091 shares

Exercise Price or Tax Liability 1 txn

Insider Sacco Christine

Role CFO & COO

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock, par value $0.01 per share	1,091	$55.09	$60K

Holdings After Transaction: Common Stock, par value $0.01 per share — 57,374 shares (Direct)

Footnotes (1)

1. F1. Reflects a correction to an inadvertent error in the number of shares held by the reporting person following the reported transaction.

Key Figures

Tax-withholding shares: 1,091 shares Transaction price: $55.09 per share Shares held after transaction: 57,374 shares +2 more

5 metrics

Tax-withholding shares 1,091 shares Shares delivered in tax-withholding disposition

Transaction price $55.09 per share Price for tax-withholding disposition

Shares held after transaction 57,374 shares Direct ownership following correction

Transaction code F Payment of exercise price or tax liability by delivering securities

Transaction direction dispose Classified as tax-withholding disposition, not open-market sale

Key Terms

tax-withholding disposition, Form 4/A, non-derivative, Payment of exercise price or tax liability by delivering securities

4 terms

tax-withholding disposition financial

"reported a tax-withholding disposition of 1,091 shares of common stock"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Form 4/A regulatory

"What insider transaction did PBH executive Christine Sacco report on this Form 4/A?"

Form 4/A is an amended filing that corrects or updates an earlier Form 4, the mandatory report that insiders (like company executives, directors, or large shareholders) must file when their ownership stakes change. Think of it as an edited receipt showing who bought or sold stock and when; investors use it to track insider confidence, detect potential conflicts, and spot trading patterns that might signal future company prospects.

non-derivative financial

"transaction_type": "non-derivative""

Payment of exercise price or tax liability by delivering securities financial

"transaction_code_description": "Payment of exercise price or tax liability by delivering securities""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did PBH executive Christine Sacco report on this Form 4/A?

Christine Sacco reported a tax-withholding disposition of Prestige Consumer Healthcare common stock. The filing shows 1,091 shares were delivered at $55.09 per share to cover obligations, rather than sold in an open-market trade, and her direct holdings were updated accordingly.

How many PBH shares were involved in Christine Sacco’s tax-withholding transaction?

The filing reports 1,091 shares of Prestige Consumer Healthcare common stock involved in the tax-withholding disposition. These shares were valued at $55.09 per share, based on the transaction price disclosed, and were used to satisfy tax or exercise-related obligations.

How many Prestige Consumer Healthcare (PBH) shares does Christine Sacco hold after this filing?

After the reported transaction, Christine Sacco directly holds 57,374 shares of Prestige Consumer Healthcare common stock. This figure reflects a correction to a prior inadvertent error and represents her updated direct ownership position following the tax-withholding disposition.

Was Christine Sacco’s PBH transaction an open-market sale or a tax withholding event?

The transaction is classified as a tax-withholding disposition, not an open-market sale. It is coded as an “F” transaction, described as payment of an exercise price or tax liability by delivering securities, indicating shares were used to satisfy obligations rather than sold on the market.

What correction does the Form 4/A for PBH’s Christine Sacco disclose?

The Form 4/A notes a correction to an inadvertent error in Sacco’s previously reported share holdings. The footnote explains that the updated 57,374-share figure reflects the correct number of shares held following the tax-withholding transaction described in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/14/2026 - 04:01 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sacco Christine

(Last) (First) (Middle)

660 WHITE PLAINS ROAD

(Street)

TARRYTOWN NEW YORK 10591

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Prestige Consumer Healthcare Inc. [ PBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO & COO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
05/05/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	05/02/2026		F		1,091	D	$55.09	57,374(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects a correction to an inadvertent error in the number of shares held by the reporting person following the reported transaction.

	/s/ Christine Sacco by William P'Pool as attorney-in-fact pursuant to power of attorney dated May 8, 2017 on file with the Commission	05/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)